Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureYichen Gu, Zixian Wang, Shuhui Xie, Binbin Wu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
10.1007/s12072-021-10276-6 · 2022
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
10.1016/j.jhep.2017.03.022 · 2017
Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases
10.1002/hep.30145 · 2019
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
2024
Early assessment of treatment response in primary biliary cholangitis: key to timely management
10.1186/s12876-025-04138-w · 2025
Application value of novel inflammatory indicators in response to ursodeoxycholic acid therapy in patients with primary biliary cholangitis
10.2147/ijgm.s493132 · 2025
Predictive model of ursodeoxycholic acid treatment response in primary biliary cholangitis
2021
Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort study
10.1186/s12876-026-04665-0 · 2026
Radiomics: the bridge between medical imaging and personalized medicine
10.1038/nrclinonc.2017.141 · 2017
Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics
10.1186/s12880-024-01398-y · 2024
Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis
10.1111/hepr.13966 · 2024
Oncology Intervention Committee of Chinese Research Hospital Society; National Health Commission Capacity Building and Continuing Education Expert Committee on Ultrasonic Diagnosis. Guideline for ultrasonic diagnosis of liver diseases [J]
2021
Ultrasonographic determination of the splenic size and its clinical usefulness in various liver diseases
10.1148/115.1.157 · 1975
Primary biliary cirrhosis
1967
Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan
10.1007/s12072-021-10163-0 · 2021
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
10.1148/radiol.2020191145 · 2020
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
10.1016/j.jhep.2019.04.001 · 2019
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
10.1002/hep.22428 · 2008
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
10.1053/j.gastro.2004.11.009 · 2005
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients
10.1007/s00535-013-0903-1 · 2014
Response to ursodeoxycholic acid may be assessed earlier to allow second-line therapy in patients with unresponsive primary biliary cholangitis
10.1007/s10620-022-07654-x · 2023
Optimizing therapy in primary biliary cholangitis: alkaline phosphatase at six months identifies one-year non-responders and predicts survival
10.1111/liv.15592 · 2023
The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis
10.1002/hep.28017 · 2016
Kupffer cells are essential for platelet-mediated thrombopoietin generation in the liver
10.1073/pnas.2517319122 · 2025
Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis
10.1038/s41598-024-82854-1 · 2024
Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI
10.1007/s00330-023-10080-w · 2024
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response
10.1111/apt.15533 · 2019
No additional external references are available.